Yingli

Yingli Ma is currently the Chief Technology Officer at Structure Therapeutics, where they lead strategy formulation and technology scouting through collaborations. Previously, they served as the President & General Manager of Basecamp Shanghai and held various leadership roles at Amgen, including Executive Director of Research. Yingli has extensive experience in structural biology and drug discovery, having led teams and projects across notable organizations such as GSK and Rockefeller University. They earned a Ph.D. in Biophysics and Molecular Biochemistry from the University of Pennsylvania.